In the last 12 months, insiders at Kyverna Therapeutics, Inc. ($KYTX) filed 80 transactions with the SEC: 7 open-market purchases totaling $47,388,987 and 1 sales totaling $292,776. Net insider sentiment: net buying.
Kyverna Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- GILEAD SCIENCES, INC. (TenPercentOwner) — 4 transactions totaling $20,020,000
- Bain Capital Life Sciences Investors, LLC (Not found) — 3 transactions totaling $9,900,000
- Northpond Ventures III GP, LLC (Not found) — 3 transactions totaling $9,900,000
- Vida Ventures, LLC (Not found) — 6 transactions totaling $5,568,992
- SEIDENBERG BETH C (Director) — 1 transaction totaling $999,998
View all SEC Filings for Kyverna Therapeutics, Inc. (KYTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | GEHCHAN NAJI | See Remarks | A | Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 43,796,170 | 9999.99% | 0.24% |
| March 13, 2026 | GEHCHAN NAJI | See Remarks | A | Common Stock | 18000 | $0.00 | 18,000.0000 | 43,796,170 | 9999.99% | 0.04% |
| March 13, 2026 | GRASSO MARC | Chief Financial Officer | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 43,796,170 | 9999.99% | 0.02% |
| March 13, 2026 | Biddle Warner Weston | Chief Executive Officer | A | Stock Option (right to buy) | 350000 | $0.00 | 350,000.0000 | 43,796,170 | 9999.99% | 0.80% |
| March 13, 2026 | Biddle Warner Weston | Chief Executive Officer | A | Common Stock | 58000 | $0.00 | 58,000.0000 | 43,796,170 | 9999.99% | 0.13% |
| March 13, 2026 | GRASSO MARC | Chief Financial Officer | A | Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 43,796,170 | 9999.99% | 0.15% |
| Feb. 24, 2026 | Miller Andrew Craig | Not found | A | Common Stock | 11006 | $0.00 | 11,006.0000 | 43,796,170 | 9999.99% | 0.03% |
| Feb. 24, 2026 | Miller Andrew Craig | Not found | A | Stock Option (right to buy) | 42945 | $0.00 | 42,945.0000 | 43,796,170 | 9999.99% | 0.10% |
| Feb. 24, 2026 | Emany Sravan Kumar | Not found | A | Stock Option (right to buy) | 42945 | $0.00 | 42,945.0000 | 43,796,170 | 9999.99% | 0.10% |
| Feb. 24, 2026 | Emany Sravan Kumar | Not found | A | Common Stock | 11006 | $0.00 | 11,006.0000 | 43,796,170 | 9999.99% | 0.03% |
| Feb. 9, 2026 | Pujols Mayobanex | Chief Technology Officer | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 43,796,170 | 9999.99% | 0.68% |
| Jan. 12, 2026 | Shaw Christi | Executive Chairperson | A | Common Stock | 24301 | $0.00 | 70,935.0000 | 43,796,170 | 52.11% | 0.06% |
| Jan. 12, 2026 | Shaw Christi | Executive Chairperson | A | Common Stock | 30000 | $0.00 | 46,634.0000 | 43,796,170 | 180.35% | 0.07% |
| Jan. 12, 2026 | Shaw Christi | Executive Chairperson | A | Stock Option (right to buy) | 185000 | $0.00 | 185,000.0000 | 43,796,170 | 9999.99% | 0.42% |
| Dec. 18, 2025 | Westlake BioPartners Opportunity Fund I, L.P. | TenPercentOwner | P | Common Stock | 133333 | $7.50 | 4,657,257.0000 | 43,796,170 | 2.95% | 0.30% |
| Dec. 18, 2025 | SEIDENBERG BETH C | Director | P | Common Stock | 133333 | $7.50 | 4,673,891.0000 | 43,796,170 | 2.94% | 0.30% |
| Dec. 15, 2025 | Walker Karen Marie | Chief Technology Officer | M | Common Stock | 23998 | $4.83 | 46,634.0000 | 43,796,170 | 106.02% | 0.05% |
| Dec. 15, 2025 | Walker Karen Marie | Chief Technology Officer | S | Common Stock | 23998 | $12.20 | 22,636.0000 | 43,796,170 | 51.46% | 0.05% |
| Dec. 15, 2025 | Walker Karen Marie | Chief Technology Officer | M | Stock option (right to buy) | 23998 | $0.00 | 85,865.0000 | 43,796,170 | 21.84% | 0.05% |
| June 30, 2025 | GRASSO MARC | Chief Financial Officer | A | Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 43,214,918 | 50.00% | 1.04% |
| May 29, 2025 | SEIDENBERG BETH C | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| May 29, 2025 | Shaw Christi | Not found | A | Common Stock | 16634 | $0.00 | 16,634.0000 | 43,214,918 | 9999.99% | 0.04% |
| May 29, 2025 | Shaw Christi | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| May 29, 2025 | SEIDENBERG BETH C | Not found | A | Common Stock | 16634 | $0.00 | 4,540,558.0000 | 43,214,918 | 0.37% | 0.04% |
| May 29, 2025 | SPIEGELMAN DANIEL K | Not found | A | Common Stock | 16634 | $0.00 | 16,634.0000 | 43,214,918 | 9999.99% | 0.04% |
| May 29, 2025 | SPIEGELMAN DANIEL K | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| May 29, 2025 | Aktar Mert | Not found | A | Common Stock | 16634 | $0.00 | 16,634.0000 | 43,214,918 | 9999.99% | 0.04% |
| May 29, 2025 | Aktar Mert | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| May 29, 2025 | CLARK IAN T | Not found | A | Common Stock | 16634 | $0.00 | 16,634.0000 | 43,214,918 | 9999.99% | 0.04% |
| May 29, 2025 | CLARK IAN T | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| May 29, 2025 | Cohen Fred E | Not found | A | Common Stock | 16634 | $0.00 | 4,540,558.0000 | 43,214,918 | 0.37% | 0.04% |
| May 29, 2025 | Cohen Fred E | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| April 11, 2024 | Biddle Warner Weston | Chief Executive Officer | A | Stock Option (right to buy) | 332500 | $0.00 | 332,500.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2024 | Jones Ryan Alexander | Chief Financial Officer | A | Stock Option (right to buy) | 74000 | $0.00 | 74,000.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2025 | Walker Karen Marie | Chief Technology Officer | A | Common Stock | 13000 | $0.00 | 22,636.0000 | 43,214,918 | 134.91% | 0.03% |
| April 11, 2024 | Walker Karen Marie | Chief Technology Officer | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2025 | Jones Ryan Alexander | Chief Financial Officer | A | Common Stock | 12000 | $0.00 | 55,950.0000 | 43,214,918 | 27.30% | 0.03% |
| Feb. 14, 2025 | Shaw Christi | Not found | A | Stock Option (right to buy) | 38679 | $0.00 | 38,679.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | GEHCHAN NAJI | See Remarks | A | Stock Option (right to buy) | 425000 | $0.00 | 425,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 21, 2024 | Aktar Mert | Not found | A | Stock Option (right to buy) | 87741 | $0.00 | 87,741.0000 | 0 | 9999.99% | 0.00% |
| Sept. 16, 2024 | Shaw Christi | Not found | A | Stock Option (right to buy) | 66592 | $0.00 | 66,592.0000 | 0 | 9999.99% | 0.00% |
| Sept. 16, 2024 | Biddle Warner Weston | Chief Executive Officer | A | Stock Option (right to buy) | 2579259 | $0.00 | 2,579,259.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Walker Karen Marie | Chief Technology Officer | M | Common Stock | 9636 | $4.42 | 9,636.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Walker Karen Marie | Chief Technology Officer | M | Stock Option (Right to Buy) | 9636 | $0.00 | 82,648.0000 | 0 | 10.44% | 0.00% |
| May 28, 2024 | Jones Ryan Alexander | Chief Financial Officer | M | Stock Option (Right to Buy) | 7146 | $0.00 | 2,192.0000 | 0 | 76.53% | 0.00% |
| May 28, 2024 | Jones Ryan Alexander | Chief Financial Officer | M | Stock Option (Right to Buy) | 10870 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Jones Ryan Alexander | Chief Financial Officer | M | Common Stock | 10870 | $0.73 | 36,804.0000 | 0 | 41.91% | 0.00% |
| May 28, 2024 | Jones Ryan Alexander | Chief Financial Officer | M | Common Stock | 7146 | $0.73 | 43,950.0000 | 0 | 19.42% | 0.00% |
| Feb. 12, 2024 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C | Common Stock | 3787940 | $0.00 | 3,787,940.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C | Common Stock | 735984 | $0.00 | 735,984.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C | Series A-1 Redeemable Convertible Preferred Stock | 4401771 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C | Series A-2 Redeemable Convertible Preferred Stock | 8830901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C | Series B Redeemable Convertible Preferred Stock | 4006624 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Westlake BioPartners Fund I, L.P. | TenPercentOwner | C | Series B Redeemable Convertible Preferred Stock | 3349538 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Bain Capital Life Sciences Investors, LLC | Not found | C | Common Stock | 2713868 | $0.00 | 2,713,868.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Bain Capital Life Sciences Investors, LLC | Not found | P | Common Stock | 450000 | $22.00 | 3,163,868.0000 | 0 | 16.58% | 0.00% |
| Feb. 12, 2024 | Bain Capital Life Sciences Investors, LLC | Not found | C | Series B Convertible Preferred Stock | 12351087 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | SEIDENBERG BETH C | Not found | C | Series B Redeemable Convertible Preferred Stock | 3349538 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Vida Ventures, LLC | Not found | C | Common Stock | 4523924 | $0.00 | 4,777,060.0000 | 0 | 1787.15% | 0.00% |
| Feb. 12, 2024 | Vida Ventures, LLC | Not found | P | Common Stock | 252553 | $22.00 | 4,777,060.0000 | 0 | 5.58% | 0.00% |
| Feb. 12, 2024 | Vida Ventures, LLC | Not found | P | Common Stock | 583 | $22.00 | 4,777,060.0000 | 0 | 0.01% | 0.00% |
| Feb. 12, 2024 | Vida Ventures, LLC | Not found | C | Series A-1 Redeemable Convertible Preferred Stock | 4401771 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Vida Ventures, LLC | Not found | C | Series A-2 Redeemable Convertible Preferred Stock | 8830901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Vida Ventures, LLC | Not found | C | Series B Redeemable Convertible Preferred Stock | 7356162 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Cohen Fred E | Not found | C | Common Stock | 4523924 | $0.00 | 4,523,924.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Cohen Fred E | Not found | C | Series A-1 Redeemable Convertible Preferred Stock | 4401771 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Cohen Fred E | Not found | C | Series A-2 Redeemable Convertible Preferred Stock | 8830901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Cohen Fred E | Not found | C | Series B Redeemable Convertible Preferred Stock | 7356162 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | SEIDENBERG BETH C | Not found | C | Common Stock | 3787940 | $0.00 | 3,787,940.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | SEIDENBERG BETH C | Not found | C | Common Stock | 735984 | $0.00 | 735,984.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | SEIDENBERG BETH C | Not found | C | Series A-1 Redeemable Convertible Preferred Stock | 4401771 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | SEIDENBERG BETH C | Not found | C | Series A-2 Redeemable Convertible Preferred Stock | 8830901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | SEIDENBERG BETH C | Not found | C | Series B Redeemable Convertible Preferred Stock | 4006624 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | C | Series B Convertible Preferred Stock | 7746139 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | C | Series A-2 Convertible Preferred Stock | 6890744 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | P | Common Stock | 910000 | $22.00 | 4,126,119.0000 | 0 | 28.29% | 0.00% |
| Feb. 12, 2024 | GILEAD SCIENCES, INC. | TenPercentOwner | C | Common Stock | 3216119 | $0.00 | 3,216,119.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Northpond Ventures III GP, LLC | Not found | P | Common Stock | 450000 | $22.00 | 3,255,426.0000 | 0 | 16.04% | 0.00% |
| Feb. 12, 2024 | Northpond Ventures III GP, LLC | Not found | C | Common Stock | 2805426 | $0.00 | 3,255,426.0000 | 0 | 623.43% | 0.00% |
| Feb. 12, 2024 | Northpond Ventures III GP, LLC | Not found | C | Series B Preferred Stock | 12767776 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |